Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Hansen, Kristian S ^a   Grieve, Eleanor ^a,b   Mikhail, Amy ^a,c   Mayan, Ismail ^c   Mohammed, Nader ^c   Anwar, Mohammed ^d   Baktash, Sayed H ^e   Drake, Thomas L ^a   Whitty, Christopher J M ^a   Rowland, Mark W ^a   Leslie, Toby J ^a,c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Health Protection and Research Organization   (Afghanistan)

^d Department of Research and Development   (Netherlands)

^e Merlin   (Afghanistan)

Author keywords

Afghanistan; Clinical diagnosis; Cost effectiveness analysis; Malaria; Microscopy diagnosis; Plasmodium falciparum; Plasmodium vivax; Rapid diagnostic test

Indexed keywords

ARTEMISININ; ARTESUNATE; CHLOROQUINE; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION;

AFGHANISTAN; ARTICLE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DRUG COST; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INTERMETHOD COMPARISON; MALARIA; MALARIA FALCIPARUM; MICROSCOPY; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PUBLIC HEALTH; RAPID DIAGNOSTIC TEST; SENSITIVITY ANALYSIS; SOCIAL NORM; ADOLESCENT; ADULT; AGED; ANIMAL; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COMBINATION; DRUG EFFECTS; ECONOMICS; INFANT; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MALARIA, VIVAX; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; AFGHANISTAN; AGED; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; DRUG COMBINATIONS; HUMANS; INFANT; MALARIA, FALCIPARUM; MALARIA, VIVAX; MICROSCOPY; MIDDLE AGED; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; YOUNG ADULT;

EID: 84930676072     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0696-1     Document Type: Article

References (44)

1. WHO. Guidelines for the treatment of malaria. 2nd ed. Geneva: World Health Organization; 2010.
2. WHO. T3: Test. Treat. Track. Scaling up diagnostic testing, treatment and surveillance for malaria. Geneva: World Health Organization; 2012.
3. Leslie T, Mikhail A, Mayan I, Cundill B, Anwar M, Bakhtash SH, et al. Rapid diagnostic tests to improve treatment of malaria and other febrile illnesses: patient randomised effectiveness trial in primary care clinics in Afghanistan. BMJ. 2014;348:g3730.
4. WHO. World Malaria Report 2013. Geneva: World Health Organization; 2013.
5. Chandramohan D, Carneiro I, Kavishwar A, Brugha R, Desai V, Greenwood B. A clinical algorithm for the diagnosis of malaria: results of an evaluation in an area of low endemicity. Trop Med Int Health. 2001;6:505-10.
6. Nankabirwa J, Zurovac D, Njogu JN, Rwakimari JB, Counihan H, Snow RW, et al. Malaria misdiagnosis in Uganda - implications for policy change. Malar J. 2009;8:66.
7. Kahama-Maro J, D'Acremont V, Mtasiwa D, Genton B, Lengeler C. Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam. Malar J. 2011;10:332.
8. Obare P, Ogutu B, Adams M, Odera JS, Lilley K, Dosoo D, et al. Misclassification of Plasmodium infections by conventional microscopy and the impact of remedial training on the proficiency of laboratory technicians in species identification. Malar J. 2013;12:113.
9. Ansah EK, Narh-Bana S, Epokor M, Akanpigbiam S, Quartey AA, Gyapong J, et al. Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana. BMJ. 2010;340:c930.
10. Leslie T, Mikhail A, Mayan I, Anwar M, Bakhtash S, Nader M, et al. Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study. BMJ. 2012;345, e4389.
11. Drakeley C, Reyburn H. Out with the old, in with the new: the utility of rapid diagnostic tests for malaria diagnosis in Africa. Trans R Soc Trop Med Hyg. 2009;103:333-7.
12. Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, et al. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev. 2011;7:CD008122.
13. World Health Organization. Malaria rapid diagnostic test performance: results of WHO product testing of malaria rapid diagnostic tests: round 2. Geneva: World Health Organisation; 2009.
14. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, et al. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ. 2007;334:403.
15. Zurovac D, Larson BA, Skarbinski J, Slutsker L, Snow RW, Hamel MJ. Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya. Am J Trop Med Hyg. 2008;78:884-91.
16. Batwala V, Magnussen P, Nuwaha F. Are rapid diagnostic tests more accurate in diagnosis of Plasmodium falciparum malaria compared to microscopy at rural health centres? Malar J. 2010;9:349.
17. Bastiaens GJH, Bousema T, Leslie T. Scale-up of malaria rapid diagnostic tests and artemisinin-based combination therapy: challenges and perspectives in sub-Saharan Africa. PLoS Med. 2014;11, e1001590.
18. Odaga J, Sinclair D, Lokong JA, Donegan S, Hopkins H, Garner P. Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings. Cochrane Database Syst Rev. 2014;4, CD008998.
19. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty CJ, et al. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ. 2008;86:101-10.
20. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, Whitty CJ, et al. The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ. 2008;336:202-5.
21. Mosha JF, Conteh L, Tediosi F, Gesase S, Bruce J, Chandramohan D, et al. Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS One. 2010;5, e8707.
22. Rolland E, Checchi F, Pinoges L, Balkan S, Guthmann JP, Guerin PJ. Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health. 2006;11:398-408.
23. Batwala V, Magnussen P, Hansen KS, Nuwaha F. Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J. 2011;10:372.
24. Ansah EK, Epokor M, Whitty CJ, Yeung S, Hansen KS. Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana. Am J Trop Med Hyg. 2013;89:724-36.
25. Chanda P, Castillo-Riquelme M, Masiye F. Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia. Cost Eff Res Alloc. 2009;7:5.
26. Lubell Y, Hopkins H, Whitty CJ, Staedke SG, Mills A. An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malar J. 2008;7:21.
27. Harchut K, Standley C, Dobson A, Klaassen B, Rambaud-Althaus C, Althaus F, et al. Over-diagnosis of malaria by microscopy in the Kilombero Valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests. Malar J. 2013;12:159.
28. Sabri B, Siddiqi S, Ahmed AM, Kakar FK, Perrot J. Towards sustainable delivery of health services in Afghanistan: options for the future. Bull World Health Organ. 2007;85:712-8.
29. Edward A, Kumar B, Kakar F, Salehi AS, Burnham G, Peters DH. Configuring balanced scorecards for measuring health system performance: evidence from 5 years' evaluation in Afghanistan. PLoS Med. 2011;8, e1001066.
30. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
31. Conteh L, Walker D. Cost and unit cost calculations using step-down accounting. Health Policy Plan. 2004;19:127-35.
32. Luce BR, Manning WG, Siegel JE, Lipscomp J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996. p. 176-213.
33. Wordsworth S, Ludbrook A, Caskey F, Macleod A. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ. 2005;6:38-44.
34. World Bank Indicators. [http://data.worldbank.org/indicator/NY.GDP.PCAP.CD?page=1].
35. Briggs A, Claxton C, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
36. Briggs A. Handling uncertainty in economic evaluation and presenting the results. In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care. Oxford: Oxford University Press; 2001. p. 172-214.
37. Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S. Applied methods of cost-effectiveness analysis in health care. Oxford: Oxford University Press; 2011.
38. Briggs AH, Ades AE, Price MJ. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Med Decis Making. 2003;23:341-50.
39. O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res. 2002;11:455-68.
40. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ. 2004;13:405-15.
41. Kolaczinski K, Durrani N, Rahim S, Rowland M. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan. Trans R Soc Trop Med Hyg. 2007;101:1081-7.
42. Awab GR, Pukrittayakamee S, Imwong M, Dondorp AM, Woodrow CJ, Lee SJ, et al. Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial. Malar J. 2010;9:105.
43. Mikhail AF, Leslie TJ, Mayan MI, Zekria R, Mohammad N, Hasanzai MA, et al. Field trial of three different Plasmodium vivax-detecting rapid diagnostic tests with and without evaporative cool box storage in Afghanistan. Malar J. 2011;10:169.
44. Wiseman V, Kim M, Mutabingwa TK, Whitty CJ. Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med. 2006;3, e373.